Nuclear Reprogramming and the Cancer Genome 2014(October 31- November 2, 2014, Guangzhou)

发布日期：2014-10-31　　浏览次数：4060

Understanding how cell fate is controlled is fundamental to all aspects of biology. Potentially, there are many cellular states that cells could adopt based on the thousands of genetic and epigenetic elements present in the genome, but in reality cell fate is constrained by signals from surrounding cells and environments. One clear example of this was shown by the transfer of a nucleus from a melanoma cell into a mouse oocyte, which produced totipotent embryonic stem cells. Why and how does this reprogramming occur? This conference aims to bring together researchers working on nuclear reprogramming, cancer genomics and the functional analysis of cancer cells to see just how much we can learn from one another.

SPEAKERS
KEYNOTE SPEAKERS:
Andrew Feinberg (John Hopkins University, USA)
Wolf Reik (The Babraham Institute, University of Cambridge, USA)

CONFIRMED SPEAKERS:
Sung Hee Baek (Seoul National University, Korea)
Xin Yuan Fu (Cancer Science Institute of Singapore, NUS, Singapore)
Jun Lu (Yale University, USA)
Martin Pera (University of Melbourne, Australia)
Jie Qiao (Peking University Third Hospital, China)
Bing Ren (University of California, San Diego, USA)
Ramesh Shivdasani (Dana Farber Cancer Institute, USA)
Yang Xu (University of California, San Diego, USA)
Yasuhiro Yamada (Kytoto University, Japan)
Kang Zhang (University of California, San Diego, USA)
Yi Zhang (Harvard Medical School, USA)

ORGANIZERS:
Myles Axton (Nature Genetics, USA)
Sarah Seton-Rogers (Nature Reviews Cancer, UK)
Natalie DeWitt (California Institute for Regenerative Medicine, USA)
Xin Lu (Ludwig Institute for Cancer Research, University of Oxford, UK)
Duanqing Pei (Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, China)

For more information and to register, visit: For more information and to register, visit: www.nature.com/natureconferences/nrcg2014